You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

33 search results for: asthma

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With <b>Asthma</b>
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
EAACI 2023 | Pediatric Severe <b>Asthma</b>: Why Lung Function Matters
expert video

EAACI 2023 | Pediatric Severe Asthma: Why Lung Function Matters

Pulmonology
Join Prof. Monika Gappa and Dr. Leonard Bacharier as they explore the importance of lung function in pediatric asthma disease progression
View more
How Can Biologics Improve Lung Function in Pediatric Severe <b>Asthma</b>?
expert video

How Can Biologics Improve Lung Function in Pediatric Severe Asthma?

Pulmonology
Dr. Leonard Bacharier discusses the role of biologics in the improvement of lung function in pediatric severe asthma
View more
Eosinophils as a Biomarker for Type 2 <b>Asthma</b>
expert video

Eosinophils as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.
View more
FeNO as a Biomarker for Type 2 <b>Asthma</b>
expert video

FeNO as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation, and its role in the disease burden of asthma.
View more
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric <b>Asthma</b> in Children 6-11 Years of Age
interactivity

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

Pulmonology
Explore GINA-based recommendations for identifying risk factors, optimizing management plans, and monitoring disease progression in pediatric asthma.
View more
On-Treatment Clinical Remission in <b>Asthma</b> Patients Case Tool
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pulmonology
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.
View more
On-Treatment <b>Asthma</b> Remission: Moving Beyond Control
interactivity

On-Treatment Asthma Remission: Moving Beyond Control

Pulmonology
Learn about the proposed framework for clinical remission in patients with asthma
View more
<b>Asthma</b> White Board Video
videoanimation

Asthma White Board Video

Pulmonology
Learn about type 2 inflammation in asthma, and the burden of asthma on patients and their families.
View more
IgE as a Biomarker for Type 2 <b>Asthma</b>
expert video

IgE as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.
View more
Type 2 Inflammation Underpins Pediatric Severe <b>Asthma</b>
Infographic

Type 2 Inflammation Underpins Pediatric Severe Asthma

Pulmonology
Learn about the role type 2 inflammation plays in the burden and pathophysiology of severe asthma in pediatric patients.
View more
Importance of Lung Function Assessment in Pediatric <b>Asthma</b> Patients
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

Pulmonology
Review the burden associated with lung function decline in pediatric patients with severe asthma, and the value of clinical lung function assessments.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FranceChange country/region